Skip to main content
SpringerLink
Log in

Infection: Myocarditis

  • Chapter
  • First Online:
Imaging of Inflammation and Infection in Cardiovascular Diseases

Abstract

Myocarditis is an inflammatory condition affecting the myocardium, variably caused by infectious agents, autoimmune conditions, or reactions to exogenous/endogenous substances. The exact incidence of myocarditis is unknown. The clinical presentation is very heterogeneous and the disease remains an underdiagnosed cause of acute heart failure, sudden death, and chronic dilated cardiomyopathy. Endomyocardial biopsy is still considered the diagnostic gold standard but is not free of risks, can have false negative results, and is of variable diagnostic accuracy. As a consequence, many efforts have been recently made to improve a non-invasive diagnostic approach, exploiting cardiovascular magnetic resonance, positron emission tomography, and molecular imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Drory Y, Turetz Y, Hiss Y, Lev B, Fisman EZ, Pines A, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol. 1991;68(13):1388–92.

    Article  CAS  PubMed  Google Scholar 

  2. Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132(17):1667–78.

    Article  PubMed  Google Scholar 

  3. Rose NR. Viral myocarditis. Curr Opin Rheumatol. 2016;28(4):383–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Cooper LT, Keren A, Sliwa K, Matsumori A, Mensah GA. The global burden of myocarditis: part 1: a systematic literature review for the global burden of diseases, injuries, and risk factors 2010 study. Glob Heart. 2014;9(1):121–9.

    Article  PubMed  Google Scholar 

  5. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2362–71.

    Article  PubMed  Google Scholar 

  6. Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2013;34(33):2636–48.

    Article  PubMed  Google Scholar 

  7. Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010;122(9):900–9.

    Article  PubMed  Google Scholar 

  8. Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158–76.

    Article  PubMed  Google Scholar 

  9. Andréoletti L, Lévêque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Arch Cardiovasc Dis. 2009;102(6–7):559–68.

    Article  PubMed  Google Scholar 

  10. Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest. 2000;80(7):1137–42.

    Article  CAS  PubMed  Google Scholar 

  11. Karatolios K, Maisch B, Pankuweit S. Suspected inflammatory cardiomyopathy. Prevalence of Borrelia burgdorferi in endomyocardial biopsies with positive serological evidence. Herz. 2015;40:91–5.

    Article  PubMed  Google Scholar 

  12. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109–23.

    Article  PubMed  Google Scholar 

  13. Engler RJM, Nelson MR, Collins LC, Spooner C, Hemann BA, Gibbs BT, et al. A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination. PLoS One. 2015;10(3):e0118283.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Maleszewski JJ, Orellana VM, Hodge DO, Kuhl U, Schultheiss H-P, Cooper LT. Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis. Am J Cardiol. 2015;115(12):1733–8.

    Article  PubMed  Google Scholar 

  15. Shi Y, Chen C, Lisewski U, Wrackmeyer U, Radke M, Westermann D, et al. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo. J Am Coll Cardiol. 2009;53(14):1219–26.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang P, Cox CJ, Alvarez KM, Cunningham MW. Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol. 2009;183(1):27–31.

    Article  CAS  PubMed  Google Scholar 

  17. Noutsias M, Rohde M, Göldner K, Block A, Blunert K, Hemaidan L, et al. Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy. Eur J Heart Fail. 2011;13(6):611–8.

    Article  CAS  PubMed  Google Scholar 

  18. Heymans S, Eriksson U, Lehtonen J, Cooper LT. The quest for new approaches in myocarditis and inflammatory cardiomyopathy. J Am Coll Cardiol. 2016;68(21):2348–64.

    Article  PubMed  Google Scholar 

  19. Caforio ALP, Marcolongo R, Jahns R, Fu M, Felix SB, Iliceto S. Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev. 2013;18(6):715–32.

    Article  CAS  PubMed  Google Scholar 

  20. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, et al. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med. 1999;27(7):1309–18.

    Article  CAS  PubMed  Google Scholar 

  21. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005;112(13):1965–70.

    Article  PubMed  Google Scholar 

  22. Elamm C, Fairweather D, Cooper LT. Pathogenesis and diagnosis of myocarditis. Heart. 2012;98(11):835–40.

    Article  CAS  PubMed  Google Scholar 

  23. Hufnagel G, Pankuweit S, Richter A, Schönian U, Maisch B. The European study of epidemiology and treatment of cardiac inflammatory diseases (ESETCID). First epidemiological results. Herz. 2000;25(3):279–85.

    Article  CAS  PubMed  Google Scholar 

  24. Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e579–646.

    PubMed  Google Scholar 

  25. Cooper LT, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant cell myocarditis study group investigators. N Engl J Med. 1997;336(26):1860–6.

    Article  PubMed  Google Scholar 

  26. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116(19):2216–33.

    Article  PubMed  Google Scholar 

  27. Patel RAG, DiMarco JP, Akar JG, Voros S, Kramer CM. Chagas myocarditis and syncope. J Cardiovasc Magn Reson. 2005;7(4):685–8.

    Article  PubMed  Google Scholar 

  28. Costello JM, Alexander ME, Greco KM, Perez-Atayde AR, Laussen PC. Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics. 2009;123(5):e835–41.

    Article  PubMed  Google Scholar 

  29. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol. 2011;4(3):303–9.

    Article  PubMed  Google Scholar 

  30. Fairweather D, Cooper LT, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr Probl Cardiol. 2013;38(1):7–46.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119(8):1085–92.

    Article  PubMed  Google Scholar 

  32. Nugent AW, Daubeney PEF, Chondros P, Carlin JB, Cheung M, Wilkinson LC, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348(17):1639–46.

    Article  PubMed  Google Scholar 

  33. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation. 2001;104(1):39–45.

    Article  CAS  PubMed  Google Scholar 

  34. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T, et al. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008;118(6):639–48.

    Article  PubMed  Google Scholar 

  35. Heymans S. Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools. Eur Heart J. 2007;28(11):1279–80.

    Article  PubMed  Google Scholar 

  36. Ukena C, Mahfoud F, Kindermann I, Kandolf R, Kindermann M, Böhm M. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011;13(4):398–405.

    Article  PubMed  Google Scholar 

  37. Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol. 2000;36(1):227–32.

    Article  CAS  PubMed  Google Scholar 

  38. Escher F, Kasner M, Kühl U, Heymer J, Wilkenshoff U, Tschöpe C, et al. New echocardiographic findings correlate with intramyocardial inflammation in endomyocardial biopsies of patients with acute myocarditis and inflammatory cardiomyopathy. Mediat Inflamm. 2013;2013:875420.

    Article  Google Scholar 

  39. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1(1):3–14.

    CAS  PubMed  Google Scholar 

  40. Shields RC, Tazelaar HD, Berry GJ, Cooper LT. The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. J Card Fail. 2002;8(2):74–8.

    Article  PubMed  Google Scholar 

  41. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc. 1989;64(10):1235–45.

    Article  CAS  PubMed  Google Scholar 

  42. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White paper. J Am Coll Cardiol. 2009;53(17):1475–87.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, et al. Recognition and initial Management of Fulminant Myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141(6):e69–92.

    Article  PubMed  Google Scholar 

  44. Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol. 1983;52(1):184–8.

    Article  CAS  PubMed  Google Scholar 

  45. Eitel I, Friedrich MG. T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson. 2011;13:13.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis JM, Ntusi N, et al. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson. 2014;16:36.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Ismail TF, Prasad SK, Pennell DJ. Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy. Heart. 2012;98(6):438–42.

    Article  PubMed  Google Scholar 

  48. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109(10):1250–8.

    Article  PubMed  Google Scholar 

  49. Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J. 2007;28(10):1242–9.

    Article  CAS  PubMed  Google Scholar 

  50. Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014;16:2.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR working Group of the European Society of cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson. 2016;18(1):89.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Kotanidis CP, Bazmpani MA, Haidich AB, Karvounis C, Antoniades C, Karamitsos TD. Diagnostic accuracy of cardiovascular magnetic resonance in acute myocarditis: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2018;11(11):1583–90.

    Article  PubMed  Google Scholar 

  54. Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res. 2016;118(3):496–514.

    Article  CAS  PubMed  Google Scholar 

  55. Ho JS, Sia C-H, Chan MY, Lin W, Wong RC. Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung. 2020;49(6):681–5.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–71.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Dillinger JG, Benmessaoud FA, Pezel T, Voicu S, Sideris G, Chergui N, et al. Coronary artery calcification and complications in patients with COVID-19. JACC Cardiovasc Imaging. 2020;13(11):2468–70.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Garot J, Amour J, Pezel T, Dermoch F, Messadaa K, Felten M-L, et al. SARS-CoV-2 fulminant myocarditis. JACC Case Rep. 2020;2(9):1342–6.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265–73.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Nagel E, Puntmann VO. Errors in statistical numbers and data in study of cardiovascular magnetic resonance imaging in patients recently recovered from COVID-19. JAMA Cardiol. 2020;5(11):1307–8.

    Article  PubMed  Google Scholar 

  61. Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330–9.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Esposito A, Palmisano A, Natale L, Ligabue G, Peretto G, Lovato L, et al. Cardiac magnetic resonance characterization of myocarditis-like acute cardiac syndrome in COVID-19. JACC Cardiovasc Imaging. 2020;13(11):2462–5.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Basso C, Leone O, Rizzo S, De Gaspari M, van der Wal AC, Aubry M-C, et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. 2020;41(39):3827–35.

    Article  CAS  PubMed  Google Scholar 

  64. Sengupta PP, Chandrashekhar YS. Cardiac involvement in the COVID-19 pandemic. JACC Cardiovasc Imaging. 2020;13(11):2480–3.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19(1):75.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Mavrogeni S, Bratis K, Markussis V, Spargias C, Papadopoulou E, Papamentzelopoulos S, et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus. 2013;22(1):34–43.

    Article  CAS  PubMed  Google Scholar 

  68. Burkard T, Trendelenburg M, Daikeler T, Hess C, Bremerich J, Haaf P, et al. The heart in systemic lupus erythematosus - a comprehensive approach by cardiovascular magnetic resonance tomography. PLoS One. 2018;13(10):e0202105.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  69. Hinojar R, Foote L, Sangle S, Marber M, Mayr M, Carr-White G, et al. Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment. Int J Cardiol. 2016;222:717–26.

    Article  PubMed  Google Scholar 

  70. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005 Mar;52(3):722–32.

    Article  PubMed  Google Scholar 

  71. Kitas G, Banks MJ, Bacon PA. Cardiac involvement in rheumatoid disease. Clin Med. 2001;1(1):18–21.

    Article  CAS  Google Scholar 

  72. Turiel M, Sitia S, Atzeni F, Tomasoni L, Gianturco L, Giuffrida M, et al. The heart in rheumatoid arthritis. Autoimmun Rev. 2010;9(6):414–8.

    Article  CAS  PubMed  Google Scholar 

  73. Chand EM, Freant LJ, Rubin JW. Aortic valve rheumatoid nodules producing clinical aortic regurgitation and a review of the literature. Cardiovasc Pathol. 1999;8(6):333–8.

    Article  CAS  PubMed  Google Scholar 

  74. Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther. 2010;12(5):R171.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging. 2015;8(5):526–36.

    Article  PubMed  Google Scholar 

  76. van Albada-Kuipers GA, Bruijn JA, Westedt ML, Breedveld FC, Eulderink F. Coronary arteritis complicating rheumatoid arthritis. Ann Rheum Dis. 1986;45(11):963–5.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685–99.

    Article  PubMed  Google Scholar 

  78. Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M, et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum. 2014;43(4):526–35.

    Article  PubMed  Google Scholar 

  79. Mousseaux E, Agoston-Coldea L, Marjanovic Z, Stanciu R, Deligny C, Perdrix L, et al. Left ventricle replacement fibrosis detected by CMR associated with cardiovascular events in systemic sclerosis patients. J Am Coll Cardiol. 2018;71(6):703–5.

    Article  PubMed  Google Scholar 

  80. Krumm P, Mueller KA, Klingel K, Kramer U, Horger MS, Zitzelsberger T, et al. Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis. J Cardiovasc Magn Reson. 2016;18(1):70.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, et al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson. 2014;16:21.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Mavrogeni S, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Raftakis J, et al. Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria. BMC Cardiovasc Disord. 2017;17(1):187.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Geri G, Wechsler B, Thi Huong du L, Isnard R, Piette JC, Amoura Z, et al. Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Medicine. 2012;91(1):25–34.

    Article  PubMed  Google Scholar 

  84. Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behcet’s disease: an update. Curr Opin Rheumatol. 2011;23(1):24–31.

    Article  PubMed  Google Scholar 

  85. Demirelli S, Degirmenci H, Inci S, Arisoy A. Cardiac manifestations in Behcet’s disease. Intractable Rare Dis Res. 2015;4(2):70–5.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Raman SV, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Magn Reson. 2012;14:82.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Wi J, Choi HH, Lee CJ, Kim T, Shin S, Ko YG, et al. Acute myocardial infarction due to Polyarteritis Nodosa in a young female patient. Korean Circ J. 2010;40(4):197–200.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Holsinger DR, Osmundson PJ, Edwards JE. The heart in periarteritis nodosa. Circulation. 1962;25:610–8.

    Article  CAS  PubMed  Google Scholar 

  89. Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol. 2017;70(19):2363–75.

    Article  PubMed  Google Scholar 

  90. Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, et al. Churg-Strauss syndrome. Autoimmun Rev. 2015;14(4):341–8.

    Article  CAS  PubMed  Google Scholar 

  91. Greulich S, Kitterer D, Kurmann R, Henes J, Latus J, Gloekler S, et al. Cardiac involvement in patients with rheumatic disorders: data of the RHEU-M(a)R study. Int J Cardiol. 2016;224:37–49.

    Article  PubMed  Google Scholar 

  92. Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis study group cohort. Arthritis Rheum. 2013;65(1):270–81.

    Article  PubMed  Google Scholar 

  93. Szczeklik W, Miszalski-Jamka T, Mastalerz L, Sokolowska B, Dropinski J, Banys R, et al. Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Circ J. 2011;75(3):649–55.

    Article  PubMed  Google Scholar 

  94. Grimaldi A, Mocumbi AO, Freers J, Lachaud M, Mirabel M, Ferreira B, et al. Tropical endomyocardial fibrosis: natural history, challenges, and perspectives. Circulation. 2016;133(24):2503–15.

    Article  CAS  PubMed  Google Scholar 

  95. Ackerman SJ, Bochner BS. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunol Allergy Clin N Am. 2007;27(3):357–75.

    Article  Google Scholar 

  96. Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, et al. Myocarditis in patients treated with immune checkpoint inhibitors. J Am Coll Cardiol. 2018;71(16):1755–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol. 2018;4(12):1721–8.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Palaskas N, Lopez-Mattei J, Durand JB, Iliescu C, Deswal A. Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment. J Am Heart Assoc. 2020;9(2):e013757.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Egred M, Davis GK. Cocaine and the heart. Postgrad Med J. 2005;81(959):568–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Rijal S, Cavalcante JL. Acute cocaine myocarditis: a word of caution. Eur Heart J. 2015;36(15):946.

    Article  PubMed  Google Scholar 

  101. Rai SK, Choi HK, Sayre EC, Avina-Zubieta JA. Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. Rheumatology. 2016;55(3):461–9.

    PubMed  Google Scholar 

  102. Schmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, et al. Elevated cardiac troponin T in patients with skeletal myopathies. J Am Coll Cardiol. 2018;71(14):1540–9.

    Article  CAS  PubMed  Google Scholar 

  103. Zhang L, Wang GC, Ma L, Zu N. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol. 2012;35(11):686–91.

    CAS  PubMed  Google Scholar 

  104. Rosenbohm A, Buckert D, Gerischer N, Walcher T, Kassubek J, Rottbauer W, et al. Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography. J Neurol. 2015;262(4):949–56.

    Article  PubMed  Google Scholar 

  105. Cox FM, Delgado V, Verschuuren JJ, Ballieux BE, Bax JJ, Wintzen AR, et al. The heart in sporadic inclusion body myositis: a study in 51 patients. J Neurol. 2010;257(3):447–51.

    Article  PubMed  Google Scholar 

  106. Sujino Y, Kimura F, Tanno J, Nakano S, Yamaguchi E, Shimizu M, et al. Cardiac magnetic resonance imaging in giant cell myocarditis: intriguing associations with clinical and pathological features. Circulation. 2014;129(17):e467–9.

    Article  PubMed  Google Scholar 

  107. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol. 2008;52(25):2175–87.

    Article  PubMed  Google Scholar 

  108. Smith ED, Lakdawala NK, Papoutsidakis N, Aubert G, Mazzanti A, McCanta AC, et al. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or Arrhythmogenic right ventricular cardiomyopathy. Circulation. 2020;141(23):1872–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Vermij SH, Abriel H, van Veen TA. Refining the molecular organization of the cardiac intercalated disc. Cardiovasc Res. 2017;113(3):259–75.

    Article  CAS  PubMed  Google Scholar 

  110. Gao S, Chen SN, Di Nardo C, Lombardi R. Arrhythmogenic cardiomyopathy and skeletal muscle dystrophies: shared histopathological features and pathogenic mechanisms. Front Physiol. 2020;11:834.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Angelini C, Peterle E. Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy. Acta Myol. 2012;31(1):9–15.

    PubMed  PubMed Central  Google Scholar 

  112. Protonotarios A, Wicks E, Ashworth M, Stephenson E, Guttmann O, Savvatis K, et al. Prevalence of (18)F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol. 2019;284:99–104.

    Article  PubMed  Google Scholar 

  113. Peters AM, Danpure HJ, Osman S, Hawker RJ, Henderson BL, Hodgson HJ, et al. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet. 1986;2(8513):946–9.

    Article  CAS  PubMed  Google Scholar 

  114. Peters AM, Saverymuttu SH. The value of indium-labelled leucocytes in clinical practice. Blood Rev. 1987;1(1):65–76.

    Article  CAS  PubMed  Google Scholar 

  115. O’Connell JB, Henkin RE, Robinson JA, Subramanian R, Scanlon PJ, Gunnar RM. Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation. 1984;70(1):58–62.

    Article  PubMed  Google Scholar 

  116. Narula J, Khaw BA, Dec GW, Palacios IF, Southern JF, Fallon JT, et al. Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med. 1993;328(2):100–4.

    Article  CAS  PubMed  Google Scholar 

  117. Lambert K, Isaac D, Hendel R. Myocarditis masquerading as ischemic heart disease: the diagnostic utility of antimyosin imaging. Cardiology. 1993;82(6):415–22.

    Article  CAS  PubMed  Google Scholar 

  118. Narula J, Khaw BA, Dec GW, Palacios IF, Newell JB, Southern JF, et al. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol. 1996;3(5):371–81.

    Article  CAS  PubMed  Google Scholar 

  119. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187–226.

    Article  PubMed  Google Scholar 

  120. Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016;23(2):244–52.

    Article  PubMed  Google Scholar 

  121. Giorgetti A, Marras G, Genovesi D, Filidei E, Bottoni A, Mangione M, et al. Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake. J Nucl Cardiol. 2018;25(4):1364–71.

    Article  PubMed  Google Scholar 

  122. Tanimura M, Dohi K, Imanaka-Yoshida K, Omori T, Moriwaki K, Nakamori S, et al. Fulminant myocarditis with prolonged active lymphocytic infiltration after hemodynamic recovery. Int Heart J. 2017;58(2):294–7.

    Article  PubMed  Google Scholar 

  123. Moriwaki K, Dohi K, Omori T, Tanimura M, Sugiura E, Nakamori S, et al. A survival case of fulminant right-side dominant eosinophilic myocarditis. Int Heart J. 2017;58(3):459–62.

    Article  PubMed  Google Scholar 

  124. Ozawa K, Funabashi N, Daimon M, Takaoka H, Takano H, Uehara M, et al. Determination of optimum periods between onset of suspected acute myocarditis and 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium. Int J Cardiol. 2013;169(3):196–200.

    Article  PubMed  Google Scholar 

  125. Perel-Winkler A, Bokhari S, Perez-Recio T, Zartoshti A, Askanase A, Geraldino-Pardilla L. Myocarditis in systemic lupus erythematosus diagnosed by 18F-fluorodeoxyglucose positron emission tomography. Lupus Sci Med. 2018;5(1):e000265.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Besenyi Z, Ágoston G, Hemelein R, Bakos A, Nagy FT, Varga A, et al. Detection of myocardial inflammation by 18F-FDG-PET/CT in patients with systemic sclerosis without cardiac symptoms: a pilot study. Clin Exp Rheumatol. 2019;37(4):88–96.

    PubMed  Google Scholar 

  127. Nazir MS, Ismail TF, Reyes E, Chiribiri A, Kaufmann PA, Plein S. Hybrid positron emission tomography-magnetic resonance of the heart: current state of the art and future applications. Eur Heart J Cardiovasc Imaging. 2018;19(9):962–74.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, et al. Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET/MRI. J Nucl Cardiol. 2018;25(3):785–94.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King’s College London & Guy’s and St Thomas’ NHS Foundation Trust, London, UK

    Tevfik F. Ismail & Alina Hua

  2. Clinic of Cardiology, University Hospital Basel and University of Basel, Basel, Switzerland

    Philip Haaf

  3. Fondazione CNR/Regione Toscana “Gabriele Monasterio”, Pisa, Pisa, Italy

    Assuero Giorgetti

Authors
  1. Tevfik F. Ismail
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alina Hua
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philip Haaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Assuero Giorgetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Philip Haaf or Assuero Giorgetti .

Editor information

Editors and Affiliations

  1. Clinic of Radiology and Nuclear Medicine, Department of Nuclear Medicine, University Hospital of Basel and University of Basel, Basel, Switzerland

    Federico Caobelli

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ismail, T.F., Hua, A., Haaf, P., Giorgetti, A. (2021). Infection: Myocarditis. In: Caobelli, F. (eds) Imaging of Inflammation and Infection in Cardiovascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-81131-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81131-0_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81130-3

  • Online ISBN: 978-3-030-81131-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation